https://www.selleckchem.com/pr....oducts/triton-tm-x-1
001). In dogs with cAD, serum TARC concentrations correlated with CADESI-04 scores (ρ=0.457, P0.01). Furthermore, serum TARC concentrations significantly decreased in treated dogs with the attenuation of clinical signs (P0.001). Changes in serum TARC concentrations before and after treatment correlated with those in CADESI-04 scores (ρ=0.746, P0.001). Serum TARC concentrations have potential as a clinical and research tool for the objective evaluation of disease severity and therapeutic responses for cAD. Serum TARC